Clinical Trial Update: A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma [Phase 2]

View source ↗

Summary

Phase II trial comparing sunitinib to dacarbazine in metastatic uveal melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• Dacarbazine (dacarbazine)
• Sunitinib (sunitinib)

Snippet

Sponsor: The Clatterbridge Cancer Centre NHS Foundation Trust | Conditions: Metastatic Uveal Melanoma | Phase 2 | Status: COMPLETED